AUS
NZ
UK
CA
USA
IND
Shares of Aptamer Group PLC (LSE:APTA) saw a 4% increase following the announcement of an extended contract with consumer giant Unilever PLC. The partnership focuses on advancing the development of Aptamer's Optimer binders, which are being designed for use in deodorant products.
This contract extension follows successful lab-based tests and will allow the collaboration to progress to efficacy testing later this year. The Optimer binders specifically target the C-S Lyase enzyme, a key contributor to body odor, and initial laboratory results have demonstrated their effectiveness.
Unilever (LSE:ULVR), which holds a substantial 30% share in the $21 billion global deodorant market, is set to conduct further testing to explore the potential for future developments based on these promising results. The collaboration with Aptamer Group aligns with Unilever's ongoing efforts to innovate within the personal care sector.
The announcement has had a positive impact on Aptamer’s stock, which rose by 0.0095p to 0.24p in early trading. This development highlights the growing importance of Aptamer’s technology in the consumer goods sector and underscores the potential for further advancements as the partnership with Unilever progresses.
Aptamer Group’s continued work with Unilever represents a significant step forward in applying its Optimer technology to everyday products, reinforcing the company's role in driving innovation within the deodorant market. The progression to efficacy testing marks a critical phase in the development of these binders, with the potential to lead to broader applications and future collaborations.
